Related Experiment Video
Updated: Aug 13, 2026

Laser Ablation of the Zebrafish Pronephros to Study Renal Epithelial Regeneration
Published on: August 29, 2011
Role of apoptosis in the pathogenesis of acute renal failure
Ramon Bonegio1, Wilfred Lieberthal
1Renal Section, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Abstract:
Renal tubular cells die by apoptosis as well as necrosis in experimental models of ischemic and toxic acute renal failure as well as in humans with acute tubular necrosis. It is not yet possible, however, to determine the relative contribution of these two forms of cell death to loss of renal tubular cells in acute tubular necrosis. The beneficial effect of administering growth factors to animals with acute tubular necrosis is probably related to the potent antiapoptotic (survival) effects of growth factors as well as to their proliferative effects. Rapamycin inhibits both of these effects of growth factors and delays the recovery of renal function after acute tubular necrosis by inhibiting renal tubular cell regeneration and by increasing renal tubular cell loss by apoptosis. The administration of caspase inhibitors ameliorates ischemia-reperfusion injury in multiple organs including the kidney. However, the extent to which this protective effect of caspase inhibition is caused by reduced intrarenal inflammation, or by amelioration of renal tubular cell loss due to apoptosis, remains uncertain. In addition to caspase inhibition, the apoptotic pathway offers many potential targets for therapeutic interventions to prevent renal tubular cell apoptosis.
Insights
Acute tubular necrosis involves both apoptosis and necrosis. Growth factors aid recovery by reducing apoptosis, while rapamycin hinders it, delaying renal function recovery.
Area of Science:
- Nephrology
- Cell Biology
- Pathology
Background:
- Renal tubular cells undergo apoptosis and necrosis in acute kidney injury (AKI).
- The precise contribution of apoptosis to tubular cell loss in AKI remains unclear.
- Growth factors show therapeutic benefits in AKI, likely via anti-apoptotic and proliferative effects.
Purpose of the Study:
- To investigate the role of apoptosis in acute tubular necrosis.
- To evaluate the impact of rapamycin on renal tubular cell apoptosis and regeneration.
- To explore the therapeutic potential of targeting the apoptotic pathway in AKI.
Main Methods:
- Utilized experimental models of ischemic and toxic acute renal failure.
- Administered growth factors and rapamycin to assess their effects on renal function and cell death.
- Examined the effects of caspase inhibitors on ischemia-reperfusion injury.
Main Results:
- Rapamycin inhibits growth factor-induced proliferation and survival, increasing tubular cell apoptosis and delaying renal recovery.
- Caspase inhibitors show protective effects in ischemia-reperfusion injury, but the mechanisms (reduced inflammation vs. reduced apoptosis) are uncertain.
- The apoptotic pathway presents multiple targets for therapeutic intervention in AKI.
Conclusions:
- Apoptosis significantly contributes to renal tubular cell loss in AKI.
- Targeting apoptotic pathways, beyond caspase inhibition, offers promising therapeutic strategies for AKI.
- Understanding the balance between apoptosis and regeneration is crucial for AKI treatment.
Related Concept Videos
Apoptosis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

